510(k) K181135
K181135 is an FDA 510(k) premarket notification submitted by Immunalysis Corporation for the device "Immunalysis SEFRIA PCP Oral Fluid Enzyme Immunoassay". The FDA issued a decision of Substantially Equivalent on January 24, 2019. The device falls under product code LCM (Enzyme Immunoassay, Phencyclidine), a Class U device. Immunalysis Corporation has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 24, 2019
- Date Received
- April 30, 2018
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Phencyclidine
- Device Class
- Class U
- Regulation Number
- Review Panel
- TX
- Submission Type